10/28/2021 2:05:46 AM
Takeda H1 Reported EPS 117 Yen Yen; Core EPS 214 Yen
10/13/2021 8:04:17 AM
BioLife Plasma Services Announces Opening Of New Plasma Center In Worcester, MA
9/30/2021 4:21:43 AM
Takeda And JCR Pharma Announce Collaboration And License Agreement To Commercialize JR-141 For Hunter Syndrome
9/21/2021 8:04:37 AM
Mirum Pharma And Takeda Enter Licensing Deal To Develop Maralixibat For Rare Pediatric Liver Diseases In Japan
7/30/2021 2:19:03 AM
Takeda Q1 EPS Up 141.9% To 128 Yen
7/29/2021 8:34:56 AM
Takeda And Frazier Collaborate To Launch HilleVax To Develop Clinical Stage Norovirus Vaccine Candidate
7/28/2021 8:25:35 AM
FDA Grants Breakthrough Therapy Designation To Takeda’s TAK-994 For Narcolepsy Type 1
7/19/2021 6:35:15 AM
Takeda Pharma Files Corporate Governance Report With Tokyo Stock Exchange
7/10/2021 12:15:57 PM
Takeda Presents New Data From Phase 3 HELP Study Open-Label Extension Evaluating TAKHZYRO At EAACI Hybrid Congress
6/29/2021 7:36:19 AM
Takeda Pharma Files Annual Report On Form 20-F For FY2020